Costs of introducing and delivering HPV vaccines in low and lower middle income countries: Inputs for GAVI policy on introduction grant support to countries

PLoS ONE

Volumn 9, Issue 6, 2014, Pages

  Levin, Ann ^a   Wang, Susan A ^b   Levin, Carol ^c   Tsu, Vivien ^d   Hutubessy, Raymond ^b  

^a WHO   (United States)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF WASHINGTON   (United States)

^d PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DRUG TRANSPORT; FEMALE; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; INCOME; INFANT; INVESTMENT; LOWER MIDDLE INCOME GROUP; LOWEST INCOME GROUP; NATIONAL HEALTH ORGANIZATION; POPULATION DENSITY; RESOURCE MANAGEMENT; SOCIAL STATUS; STRATEGIC PLANNING; VACCINATION; DEVELOPING COUNTRY; ECONOMICS; IMMUNOLOGY; LEGISLATION AND JURISPRUDENCE; PAPILLOMAVIRUS INFECTIONS; PILOT STUDY; PREVENTIVE HEALTH SERVICE;

COST-BENEFIT ANALYSIS; DEVELOPING COUNTRIES; HUMANS; IMMUNIZATION PROGRAMS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PILOT PROJECTS; VACCINATION;

EID: 84903384856     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101114     Document Type: Article

References (16)

1. World Health Organization (2009) Position paper on Human Papillomavirus Vaccine. Wkly Epidemiol Rec 84: 118-131.
2. GAVI alliance 2012 (2012) GAVI Q&A Board Decisions November 2011.
3. GAVI Alliance (2012) GAVI Alliance Vaccine Introduction Grant and Operational Support for Campaigns Policy. April 2012.
4. Levin CE, Minh HV, Odaga J, Rout SS, Nguyen Thi Ngoc D, et al. (2013) Incremental costs of strategies to deliver human papillomavirus vaccine to young adolescent girls in Peru, Uganda and Vietnam. Bull World Health Organ. 2013; 91: 585-592.
5. Hutubessy R, Levin A, Wang S, Morgan W, Ally M, et al. (2012) A case study using the United Republic of Tanzania: costing nationwide HPV vaccine delivery using the WHO Cervical Cancer Prevention and Control Costing Tool. BMC Med 10: 136. 1741-7015-10-136 [pii]; 10.1186/1741-7015-10-136 [doi].
6. Quentin W, Terris-Prestholt F, Changalucha J, Soteli S, Edmunds WJ, et al. (2012) Costs of delivering human papillomavirus vaccination to schoolgirls in Mwanza Region, Tanzania. BMC Med 10: 137. 1741-7015-10-137 [pii]; 10.1186/1741-7015-10-137 [doi].
7. World Health Organization (2009) Periodic intensification of routine immunization: Lessons learned and implications for action (Pre-Print Release) 2009.
8. Levin A, Wang S, Hutubessy R (2013) Costs of Introducing Three New Vaccines in Rwanda: Pneumococcal, HPV, and Rotavirus. Unpublished Paper. World Health Organization, Geneva, Switzerland.
9. Monath TP, Nasidi A (1993) Should yellow fever vaccine be included in the expanded program of immunization in Africa? A cost-effectiveness analysis for Nigeria. The American Journal of Tropical Medicine and Hygiene. 48(2): 274-99. (Pubitemid 23083746)
10. PATH (2011) HPV vaccination with monthly immunization or campaign approach: technical report of demonstration projects in Andhra Pradesh and Gujarat, India.
11. Bhutan Ministry of Health (2012) Personal communication with Mr. Tandin Dorji, Chief Program Officer, Department of Public Health, Ministry of Health, Bhutan.
12. Lamontagne DS, Barge S, Le NT, Mugisha E, Penny ME, et al. (2011) Human papillomavirus vaccine delivery strategies that achieved high coverage in low-and middle-income countries. Bull World Health Organ 89: 821-830B. 10.2471/BLT.11.089862 [doi]; BLT.11.089862 [pii].
13. Brownson RC, Gurney JG, Land GH (1999) Evidence-based decision making in public health. J Public Health Manag Pract 5: 86-97.
14. Fesenfeld M, Hutubessy R, Jit M (2013) Cost-effectiveness of human papillomavirus vaccination in low and middle income countries: A systematic review. Vaccine. S0264-410X(13)00852-9 [pii]; 10.1016/j.vaccine.2013.06.060 [doi].
15. Jit M, Levin C, Brisson M, Levin A, Resch S, et al. (2013) Economic analyses to support decisions about HPV vaccination in low- and middle-income countries: a consensus report and guide for analysts. BMC Med 11: 23. 1741-7015-11-23 [pii]; 10.1186/1741-7015-11-23 [doi].
16. Jit M, Brisson M, Portnoy A, Hutubessy R (2014). Cost-effectiveness of female human papilomavirus vaccination in 179 countries: a PRIME modeling study. Lancet Global Health. In Press.